United States · FDA National Drug Code directory
PredniSONE Tablets, USP, 5 mg
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72789-474_4ddfaff7-3273-e76e-e063-6294a90a01c9
- Product NDC
- 72789-474
- Form
- TABLET
- Composition / generic term
- PredniSONE
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250522
- Source listing expiry
- 20271231
Source-listed ingredients
- PREDNISONE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE, PLASTIC (72789-474-01) · 72789-474-01
- 4 TABLET in 1 BOTTLE, PLASTIC (72789-474-04) · 72789-474-04
- 21 TABLET in 1 BOTTLE, PLASTIC (72789-474-21) · 72789-474-21
- 1000 TABLET in 1 BOTTLE, PLASTIC (72789-474-95) · 72789-474-95
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →